June 6, 2011 (Washington, DC) — A post hoc analysis of a phase 3 clinical trial of the acute migraine drug dihydroergotamine (Levadex, MAP Pharmaceuticals Inc) using 4 different previously published ...

To determine whether a variable definition of biochemical recurrence (BCR) based on clincopathologic features facilitates early identification of patients likely to suffer from disease progression.

There is no universally accepted definition for recurrence of differentiated thyroid cancer (DTC) across treatment categories such as total thyroidectomy with or without radioactive iodine ablation ...

Researchers determined that the Huber et al. criteria regarding prostate-specific antigen (PSA) levels may more accurately predict the need for additional treatment or the possibility of treatment ...

Prostate-specific antigen (PSA) defined biochemical recurrence (BCR) of prostate cancer is widely used for reporting the outcome of radical prostatectomy (RP). A standardized BCR definition is lacking ...

Regular monitoring can help identify signs of thyroid cancer recurrence. Many treatment options can help treat recurrent thyroid cancer. The thyroid uses the mineral iodine to produce essential ...

Oral cancer may recur where it initially started or elsewhere in the body. The recurrence rates differ for people with early and advanced stages of oral cancer. Oral cancer can occur anywhere in the ...

An expert task force has created a new definition for epilepsy that refines the scope of patients diagnosed with this brain disease. The study provides a greater level of detail to diagnose epilepsy ...

Prostate-specific antigen (PSA) defined biochemical recurrence (BCR) of prostate cancer is widely used for reporting the outcome of radical prostatectomy (RP). A standardized BCR definition is lacking ...